Literature DB >> 19036808

DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Trisha M Wise-Draper1, Richard J Morreale, Teresa A Morris, Rachael A Mintz-Cole, Elizabeth E Hoskins, Scott J Balsitis, Nader Husseinzadeh, David P Witte, Kathryn A Wikenheiser-Brokamp, Paul F Lambert, Susanne I Wells.   

Abstract

Overexpression of the DEK gene is associated with multiple human cancers, but its specific roles as a putative oncogene are not well defined. DEK transcription was previously shown to be induced by the high-risk human papillomavirus (HPV) E7 oncogene via E2F and Rb pathways. Transient DEK overexpression was able to inhibit both senescence and apoptosis in cultured cells. In at least the latter case, this mechanism involved the destabilization of p53 and the decreased expression of p53 target genes. We show here that DEK overexpression disrupts the normal differentiation program in a manner that is independent of either p53 or cell death. DEK expression was distinctly repressed upon the differentiation of cultured primary human keratinocytes, and stable DEK overexpression caused epidermal thickening in an organotypic raft model system. The observed hyperplasia involved a delay in keratinocyte differentiation toward a more undifferentiated state, and expansion of the basal cell compartment was due to increased proliferation, but not apoptosis. These phenotypes were accompanied by elevated p63 expression in the absence of p53 destabilization. In further support of bona fide oncogenic DEK activities, we report here up-regulated DEK protein levels in both human papilloma virus-positive hyperplastic murine skin and a subset of human squamous cell carcinomas. We suggest that DEK up-regulation may contribute to carcinoma development at least in part through increased proliferation and retardation of differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036808      PMCID: PMC2631320          DOI: 10.2353/ajpath.2009.080330

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  SAP - a putative DNA-binding motif involved in chromosomal organization.

Authors:  L Aravind; E V Koonin
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.

Authors:  Mónica Campillos; Miguel Angel García; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

3.  Structure-specific binding of the proto-oncogene protein DEK to DNA.

Authors:  Tanja Waldmann; Martina Baack; Nicole Richter; Claudia Gruss
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

4.  Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.

Authors:  Luis Miguel Mendes Soares; Katia Zanier; Cameron Mackereth; Michael Sattler; Juan Valcárcel
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

Review 5.  Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene.

Authors:  M von Lindern; M Fornerod; N Soekarman; S van Baal; M Jaegle; A Hagemeijer; D Bootsma; G Grosveld
Journal:  Baillieres Clin Haematol       Date:  1992-10

6.  Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.

Authors:  Morgan Sammons; Shan Shan Wan; Nancy L Vogel; Edwin J Mientjes; Gerard Grosveld; Brian P Ashburner
Journal:  J Biol Chem       Date:  2006-07-07       Impact factor: 5.157

7.  Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy.

Authors:  H Klump; B Schiedlmeier; B Vogt; M Ryan; W Ostertag; C Baum
Journal:  Gene Ther       Date:  2001-05       Impact factor: 5.250

8.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Solution NMR structure of the C-terminal domain of the human protein DEK.

Authors:  Matthew Devany; N Prasad Kotharu; Hiroshi Matsuo
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

10.  p63 induces key target genes required for epidermal morphogenesis.

Authors:  Maranke I Koster; Daisy Dai; Barbara Marinari; Yuji Sano; Antonio Costanzo; Michael Karin; Dennis R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

View more
  36 in total

Review 1.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

2.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

3.  The nuclear DEK interactome supports multi-functionality.

Authors:  Eric A Smith; Eric F Krumpelbeck; Anil G Jegga; Malte Prell; Marie M Matrka; Ferdinand Kappes; Kenneth D Greis; Abdullah M Ali; Amom R Meetei; Susanne I Wells
Journal:  Proteins       Date:  2017-11-11

4.  Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

Authors:  Maegan L Capitano; Nirit Mor-Vaknin; Anjan K Saha; Scott Cooper; Maureen Legendre; Haihong Guo; Rafael Contreras-Galindo; Ferdinand Kappes; Maureen A Sartor; Christopher T Lee; Xinxin Huang; David M Markovitz; Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

Review 5.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

6.  The fanconi anemia pathway limits human papillomavirus replication.

Authors:  Elizabeth E Hoskins; Richard J Morreale; Stephen P Werner; Jennifer M Higginbotham; Laimonis A Laimins; Paul F Lambert; Darron R Brown; Maura L Gillison; Gerard J Nuovo; David P Witte; Mi-Ok Kim; Stella M Davies; Parinda A Mehta; Melinda Butsch Kovacic; Kathryn A Wikenheiser-Brokamp; Susanne I Wells
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

7.  Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice.

Authors:  Suwon Jeon; Jaehwi Song; Dongyup Lee; Goon-Tae Kim; Si-Hyun Park; Dong-Yoon Shin; Kyong-Oh Shin; Kyungho Park; Soon-Mi Shim; Tae-Sik Park
Journal:  J Lipid Res       Date:  2019-11-05       Impact factor: 5.922

8.  The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.

Authors:  A Deutzmann; M Ganz; F Schönenberger; J Vervoorts; F Kappes; E Ferrando-May
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

9.  EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis.

Authors:  Zhonghua Zhang; Chang Xiao; Aaron M Gibson; Stacey A Bass; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

Review 10.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.